SCHEMBL344727

SCHEMBL344727

O=C(O)N1CC1Cc1cc(F)c(F)cc1F

nearest known ligand 0.38

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 14/20 0.38
DPP7 Q9UHL4 10/20 0.38
DPP8 Q6V1X1 9/20 0.38
DPP9 Q86TI2 5/20 0.38
FAP Q12884 2/20 0.38
CYP3A4 P08684 1/20 0.36
KCNH2 Q12809 1/20 0.36
CYP2D6 P10635 1/20 0.34
TSHR P16473 1/20 0.33
ABCB1 P08183 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL343753 0.85 ABCB1 (0.44) DPP4DPP7DPP8DPP9FAP
SCHEMBL343752 0.85 ABCB1 (0.44) DPP4DPP7DPP8DPP9FAP
SCHEMBL27963865 0.83 DPP4 (0.38) DPP4DPP7DPP8DPP9FAP
SCHEMBL28070441 0.83 DPP4 (0.38) DPP4DPP7DPP8DPP9FAP
SCHEMBL542233 0.81 DPP4 (0.39) DPP4DPP7DPP8DPP9FAP
SCHEMBL343020 0.79 DPP4 (0.51) DPP4DPP7DPP8DPP9CYP3A4
SCHEMBL343021 0.79 DPP4 (0.51) DPP4DPP7DPP8DPP9CYP3A4
SCHEMBL27963868 0.77 DPP4 (0.48) DPP4DPP7TSHR
SCHEMBL10022723 0.73 DPP4 (0.36) DPP4DPP7DPP8DPP9FAP
SCHEMBL5399422 0.72 ECE1 (0.42) DPP4DPP7DPP8DPP9FAP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103922971-B For the preparation of improving one's methods of the intermediate of dipeptidyl peptidase-iv inhibitor DONG-A ST CO., LTD. (KR) 2016-05-11 CN disclosed
US-9249109-B2 Method for preparing dipeptidyl peptidase-IV inhibitor and intermediate DONG-A PHARMACEUTICAL CO., LTD. (KR) 2016-02-02 US disclosed
US-20150025241-A1 METHOD FOR PREPARING DIPEPTIDYL PEPTIDASE-IV INHIBITOR AND INTERMEDIATE DONG-A PHARMACEUTICAL. CO., LTD (KR) 2015-01-22 US disclosed
EP-2415753-B1 METHOD FOR PREPARING DIPEPTIDYL PEPTIDASE-IV INHIBITOR AND INTERMEDIATE DONG A PHARM CO LTD (KR) 2014-08-27 EP disclosed
CN-102378751-B Improved process for preparing dipeptidyl peptidase-IV inhibitors and intermediates DONG A PHARM CO LTD 2014-08-20 CN disclosed
CN-103922971-A Improved Method For Preparing Intermediate Of Dipeptidyl Peptidase-iv Inhibitor DONG A PHARM CO LTD 2014-07-16 CN disclosed
EP-2669265-A2 Improved method for preparing dipeptidyl peptidase-IV inhibitor and intermediate Dong-A Pharmaceutical Co., Ltd. (KR) 2013-12-04 EP disclosed
EP-2415753-A2 IMPROVED METHOD FOR PREPARING DIPEPTIDYL PEPTIDASE-IV INHIBITOR AND INTERMEDIATE Dong-A Pharmaceutical Co., Ltd. (KR) 2012-02-08 EP disclosed
US-20120016125-A1 METHOD FOR PREPARING DIPEPTIDYL PEPTIDASE-IV INHIBITOR AND INTERMEDIATE DONG-A PHARMACEUTICAL. CO., LTD (KR) 2012-01-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150025241-A1 METHOD FOR PREPARING DIPEPTIDYL PEPTIDASE-IV INHIBITOR AND INTERMEDIATE DPP4, DPP3, DPP7 DPP4 1/4885DPP7 3/4885DPP8 4/4885
US-20120016125-A1 METHOD FOR PREPARING DIPEPTIDYL PEPTIDASE-IV INHIBITOR AND INTERMEDIATE DPP4, DPP3, DPP7 DPP4 1/4885DPP7 3/4885DPP8 4/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.